Antibiotic Resistance Market Scope and Size by 2031
Antimicrobial substances that is used to combat bacterial infection are termed as antibiotics. These are used to heal several medical conditions like stroke, sinus, urinary tract infections, ear infections, pneumonia, skin infections, and other diseases. The classification of antibiotics is based on chemical structures, activity spectrum, and action method. The capacity to withstand the infection is known as resistance to antibiotics. Worldwide, this is expected to be a key issue, leading to the full-fledged emergence of the global antibiotic resistance market.
MARKET DYNAMICS
The artificial intelligence in the healthcare diagnosis market is driven by many pharmaceutical companies are focusing to develop the antibiotic resistance drugs. However, lack of interest of investor for the research and development of antibiotics resistance therapies will also hamper the development of antibiotic resistance market. Moreover, rising number of patient pool suffering from bacterial infection is the primary factor driving the growth of antibiotic resistance market over the forecast period
MARKET SCOPE
The "Antibiotic Resistance Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of antibiotic resistance market with detailed market segmentation by drug class and distribution channel. The antibiotic resistance market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in antibiotic resistance market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The antibiotic resistance market is segmented on the basis of drug class and distribution channel. Based on drug class, the market is segmented as oxazolidinones, cephalosporins, tetracyclines, lipoglycopeptides and others. On the basis of distribution channel, the market is categorized as hospital pharmacies, retail pharmacies, drug stores and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the antibiotic resistance market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antibiotic resistance market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting antibiotic resistance market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antibiotic resistance market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the antibiotic resistance market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antibiotic resistance market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting antibiotic resistance market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antibiotic resistance market in these regions.
MARKET PLAYERS
The report covers key developments in the antibiotic resistance market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from antibiotic resistance market are anticipated to have lucrative growth opportunities in the future with the rising demand for antibiotic resistance in the global market. Below mentioned is the list of few companies engaged in the antibiotic resistance market.
The report also includes the profiles of key players in antibiotic resistance market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Achaogen, Inc.
- Basilea Pharmaceutica Ltd.
- Entasis Therapeutics
- Melinta Therapeutics
- PARATEK therapeutics
- Seres Therapeutics, Inc.
- Tetraphase Pharmaceuticals, Inc.
- Theravance Biopharma, Inc
- Wockhardt therapeutics
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibiotic Resistance Market - By Drug Class
1.3.2 Antibiotic Resistance Market - By Distribution Channel
1.3.3 Antibiotic Resistance Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIBIOTIC RESISTANCE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIBIOTIC RESISTANCE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIBIOTIC RESISTANCE MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBIOTIC RESISTANCE - GLOBAL MARKET OVERVIEW
6.2. ANTIBIOTIC RESISTANCE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIBIOTIC RESISTANCE MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. OXAZOLIDINONES
7.3.1. Overview
7.3.2. Oxazolidinones Market Forecast and Analysis
7.4. CEPHALOSPORINS
7.4.1. Overview
7.4.2. Cephalosporins Market Forecast and Analysis
7.5. TETRACYCLINES
7.5.1. Overview
7.5.2. Tetracyclines Market Forecast and Analysis
7.6. LIPOGLYCOPEPTIDES
7.6.1. Overview
7.6.2. Lipoglycopeptides Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. ANTIBIOTIC RESISTANCE MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. DRUG STORES
8.5.1. Overview
8.5.2. Drug Stores Market Forecast and Analysis
8.6. ONLINE PHARMACIES
8.6.1. Overview
8.6.2. Online Pharmacies Market Forecast and Analysis
9. ANTIBIOTIC RESISTANCE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antibiotic Resistance Market Overview
9.1.2 North America Antibiotic Resistance Market Forecasts and Analysis
9.1.3 North America Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.1.4 North America Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antibiotic Resistance Market
9.1.5.1.1 United States Antibiotic Resistance Market by Drug Class
9.1.5.1.2 United States Antibiotic Resistance Market by Distribution Channel
9.1.5.2 Canada Antibiotic Resistance Market
9.1.5.2.1 Canada Antibiotic Resistance Market by Drug Class
9.1.5.2.2 Canada Antibiotic Resistance Market by Distribution Channel
9.1.5.3 Mexico Antibiotic Resistance Market
9.1.5.3.1 Mexico Antibiotic Resistance Market by Drug Class
9.1.5.3.2 Mexico Antibiotic Resistance Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Antibiotic Resistance Market Overview
9.2.2 Europe Antibiotic Resistance Market Forecasts and Analysis
9.2.3 Europe Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antibiotic Resistance Market
9.2.5.1.1 Germany Antibiotic Resistance Market by Drug Class
9.2.5.1.2 Germany Antibiotic Resistance Market by Distribution Channel
9.2.5.2 France Antibiotic Resistance Market
9.2.5.2.1 France Antibiotic Resistance Market by Drug Class
9.2.5.2.2 France Antibiotic Resistance Market by Distribution Channel
9.2.5.3 Italy Antibiotic Resistance Market
9.2.5.3.1 Italy Antibiotic Resistance Market by Drug Class
9.2.5.3.2 Italy Antibiotic Resistance Market by Distribution Channel
9.2.5.4 Spain Antibiotic Resistance Market
9.2.5.4.1 Spain Antibiotic Resistance Market by Drug Class
9.2.5.4.2 Spain Antibiotic Resistance Market by Distribution Channel
9.2.5.5 United Kingdom Antibiotic Resistance Market
9.2.5.5.1 United Kingdom Antibiotic Resistance Market by Drug Class
9.2.5.5.2 United Kingdom Antibiotic Resistance Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antibiotic Resistance Market Overview
9.3.2 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis
9.3.3 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antibiotic Resistance Market
9.3.5.1.1 Australia Antibiotic Resistance Market by Drug Class
9.3.5.1.2 Australia Antibiotic Resistance Market by Distribution Channel
9.3.5.2 China Antibiotic Resistance Market
9.3.5.2.1 China Antibiotic Resistance Market by Drug Class
9.3.5.2.2 China Antibiotic Resistance Market by Distribution Channel
9.3.5.3 India Antibiotic Resistance Market
9.3.5.3.1 India Antibiotic Resistance Market by Drug Class
9.3.5.3.2 India Antibiotic Resistance Market by Distribution Channel
9.3.5.4 Japan Antibiotic Resistance Market
9.3.5.4.1 Japan Antibiotic Resistance Market by Drug Class
9.3.5.4.2 Japan Antibiotic Resistance Market by Distribution Channel
9.3.5.5 South Korea Antibiotic Resistance Market
9.3.5.5.1 South Korea Antibiotic Resistance Market by Drug Class
9.3.5.5.2 South Korea Antibiotic Resistance Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antibiotic Resistance Market Overview
9.4.2 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis
9.4.3 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antibiotic Resistance Market
9.4.5.1.1 South Africa Antibiotic Resistance Market by Drug Class
9.4.5.1.2 South Africa Antibiotic Resistance Market by Distribution Channel
9.4.5.2 Saudi Arabia Antibiotic Resistance Market
9.4.5.2.1 Saudi Arabia Antibiotic Resistance Market by Drug Class
9.4.5.2.2 Saudi Arabia Antibiotic Resistance Market by Distribution Channel
9.4.5.3 U.A.E Antibiotic Resistance Market
9.4.5.3.1 U.A.E Antibiotic Resistance Market by Drug Class
9.4.5.3.2 U.A.E Antibiotic Resistance Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antibiotic Resistance Market Overview
9.5.2 South and Central America Antibiotic Resistance Market Forecasts and Analysis
9.5.3 South and Central America Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antibiotic Resistance Market
9.5.5.1.1 Brazil Antibiotic Resistance Market by Drug Class
9.5.5.1.2 Brazil Antibiotic Resistance Market by Distribution Channel
9.5.5.2 Argentina Antibiotic Resistance Market
9.5.5.2.1 Argentina Antibiotic Resistance Market by Drug Class
9.5.5.2.2 Argentina Antibiotic Resistance Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIBIOTIC RESISTANCE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIBIOTIC RESISTANCE MARKET, KEY COMPANY PROFILES
12.1. ACHAOGEN, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BASILEA PHARMACEUTICA LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ENTASIS THERAPEUTICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MELINTA THERAPEUTICS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PARATEK THERAPEUTICS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SERES THERAPEUTICS, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TETRAPHASE PHARMACEUTICALS, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. THERAVANCE BIOPHARMA, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. WOCKHARDT THERAPEUTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Achaogen, Inc.
2. Basilea Pharmaceutica Ltd.
3. Entasis Therapeutics
4. Melinta Therapeutics
5. PARATEK therapeutics
6. Seres Therapeutics, Inc.
7. Tetraphase Pharmaceuticals, Inc.
8. Theravance Biopharma, Inc
9. Wockhardt therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For